INEX PHARMACEUTICALS

Inex Pharmaceuticals

#SimilarOrganizations #More

INEX PHARMACEUTICALS

Industry:
Biotechnology

Status:
Active


Similar Organizations

not_available_image

Auda Pharmaceuticals

Auda Pharmaceuticals.

not_available_image

Catena Pharmaceuticals

Catena Pharmaceuticals.

not_available_image

Faust Pharmaceuticals

Faust Pharmaceuticals

not_available_image

ImCure Therapeutics

ImCure Therapeutics

not_available_image

Kuhnil Pharmaceutical

Kuhnil Pharmaceutical

not_available_image

Nastech Pharmaceutical

Nastech Pharmaceutical

senexta-therapeutics-logo

Senexta Therapeutics

Senexta Therapeutics

not_available_image

WibiWorks Pharmaceuticals

WibiWorks Pharmaceuticals

yichang-sanxia-pharmaceutical-logo

Yichang Sanxia Pharmaceutical

Yichang Sanxia Pharmaceutical

More informations about "Inex Pharmaceuticals"

Inex Pharmaceuticals - White Rose Wiki

¶Inex Pharmaceuticals. Inex Pharmaceuticals was a Canadian biopharmaceutical company based in Vancouver, British Columbia. It was the predecessor to Tekmira Pharmaceuticals. ¶ History โ€ฆSee details»

Inex Pharmaceuticals - Drug pipelines, Patents, Clinical trials

Nov 1, 2024 Explore Inex Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 1 news, and 3 literature, Drug:INX-4437, INXC-6295, INX-3280. ...See details»

Organization | Inex Pharmaceuticals

Inex Pharmaceuticals Report issue. For profit Phase 2. Founded: Vancouver BC Canada ... Organization Overview. First Clinical Trial. 2000 NCT00006383. First Marketed Drug. None ...See details»

Acuitas Therapeutics - Wikipedia

Pieter Cullis was among several scientists experimenting with liposomes in the early 1980s, fascinated by their properties in many aspects of human biology. Cullis discovered he could load cancer drugs into liposomes, inspiring him and several colleagues at the University of British Columbia to form Inex Pharmaceuticals in 1992. One of Inex's co-founders was Thomas Madden, who had recently emigrated to Canada from the United Kingdom to complete post-doctoral studieโ€ฆSee details»

Inex Pharmaceuticals - Crunchbase Company Profile & Funding

Organization. Inex Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Inex Pharmaceuticals is a biopharmaceutical business โ€ฆSee details»

Inex Pharmaceuticals Corp - Company Profile and News

Inex Pharmaceuticals Corporation is a biopharmaceutical company that utilizes compounds and proprietary delivery systems to increase the effectiveness and reduce the side effects of anti โ€ฆSee details»

BioPharmaLink profile of Inex Pharmaceuticals Corporation, Canada,

Inex Pharmaceuticals Corporation . Inex has assembled a portfolio of transmembrane carrier systems (TCS) that will enhance the delivery of many of the new classes of therapeutic agents โ€ฆSee details»

Inex Pharmaceuticals Corp. - BioCentury Company Profiles - BCIQ

Apr 15, 2013 Inex Pharmaceuticals Corp. - BioCentury Company Profiles for the biopharma industrySee details»

Inex Pharmaceuticals Corporation - White Pages Canada

Inex Pharmaceuticals Corporation is located at 8900 Glenlyon Parkway, Burnaby, BC. The postal code is V5J5J8. You can contact Inex Pharmaceuticals Corporation at 604-419-3200 or from โ€ฆSee details»

Inex Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks

Organization. Inex Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. About. Inex โ€ฆSee details»

David Main โ€“ Inex Pharmaceutical Corporation (iex.to)

Oct 1, 2001 DAVID J. MAIN was appointed President and CEO of Inex Pharmaceutical Corporation on July 1, 1999 and since that time the company has advanced its lead product to โ€ฆSee details»

INEX PHARMACEUTICALS CORP innovation strategy - GoodIP

INEX PHARMACEUTICALS CORP has a total of 165 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, WIPO (World Intellectual โ€ฆSee details»

Patents Assigned to Inex Pharmaceuticals Corporation

Mar 7, 2008 Abstract: The present invention relates generally to the amphiphilic polyelectrolyte, poly(2-ethylacrylic acid) and covalently bonded lipids to generate Lipo-PEAA. These Lipo โ€ฆSee details»

Co-founded Inex Pharmaceuticals with four members of his UBC โ€ฆ

Health organization. Health care is a system comprising people, institutions & resources along with the training, policies, structure and organizational leadership that make it all happen. โ€ฆSee details»

Patents Assigned to Inex Pharmaceuticals Corp.

Jul 14, 2000 Assignee: Inex Pharmaceuticals Corp. Inventors: Ellen K. Wasan, Marcel B. Bally, Michael J. Hope, Dorothy L. Reimer, Quet Fah Ahkong Compositions for the introduction of โ€ฆSee details»

INXC-6295 - Drug Targets, Indications, Patents - Synapse - Patsnap

INXC-6295, Initially developed by Inex Pharmaceuticals, Now, its global highest R&D status is Discontinued, Therapeutic Areas: Neoplasms. ... Originator Organization. Inex โ€ฆSee details»

C$40 million financing at Inex - Pharmaceutical industry news | The ...

Nov 23, 2001 Inex Pharmaceuticals Corp of Canada has entered into an agreement with asyndicate of underwriters, led by BMO Nesbitt Burns, which has agreed to buy over 5.7 โ€ฆSee details»

Inex Pharmaceuticals: Contact Details and Business Profile

Inex Pharmaceuticals is a Pharmaceutical Manufacturing, Pharmaceuticals, and Healthcare company located in US with $8.40 Million in revenue and 5 employees. Find top employees, โ€ฆSee details»

Inex Pharmaceuticals Corp (IEX-T) - Stockchase

On , Inex Pharmaceuticals Corp (IEX-T) stock closed at a price of $. Your Watchlist Add stocks to watchlist to monitor them daily and get important alerts. Get Access To Watchlist Get Access โ€ฆSee details»

linkstock.net © 2022. All rights reserved